Halting TB Transmission in HIV-Endemic and Other High-Transmission Settings (R01 Clinical Trial Not Allowed)

Funding Agency:
National Institutes of Health

The objectives of this Funding Opportunity Announcement are to promote research to:

1) understand the critical drivers of TB transmission at the individual and population levels in high-burden settings, particularly where high incidence of HIV co-infection contributes to TB rates. (This may include the aerobiology of infectious particles and environmental- and population-based factors.)

2) develop potential interventions to prevent TB transmission in HIV-endemic and other high-transmission settings and to measure the rate of transmission underpinned by an increased understanding of the biomedical basis of transmission and related risk factors.   


  • Letter of Intent Duke Date(s): November 5, 2018
  • Application Due Date(s): December 5, 2018
  • AIDS Application Due Date(s): December 5, 2018

RFA-AI-18-037 Expiration Date December 6, 2018

Agency Website

Eligibility Requirements


Amount Description



Funding Type





International Opportunities
Medical - Basic Science
Medical - Clinical Science
Medical - Translational

External Deadline

December 5, 2018